PMC:7195088 / 16108-16308 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"657","span":{"begin":130,"end":138},"obj":"Species"},{"id":"742","span":{"begin":67,"end":86},"obj":"Chemical"},{"id":"743","span":{"begin":91,"end":110},"obj":"Chemical"},{"id":"744","span":{"begin":116,"end":126},"obj":"Chemical"},{"id":"910","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A657","pred":"tao:has_database_id","subj":"657","obj":"Tax:9606"},{"id":"A742","pred":"tao:has_database_id","subj":"742","obj":"MESH:C558899"},{"id":"A743","pred":"tao:has_database_id","subj":"743","obj":"MESH:C558899"},{"id":"A744","pred":"tao:has_database_id","subj":"744","obj":"MESH:C086979"},{"id":"A910","pred":"tao:has_database_id","subj":"910","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"m Hg or respiratory rate ≥ 30 breaths per minute).\n• Comparison of lopinavir/ritonavir vs. lopinavir/ritonavir plus umifenovir in patients with COVID-19. Open-label RCT (NCT04252885, recruiting). Prim"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T79","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"m Hg or respiratory rate ≥ 30 breaths per minute).\n• Comparison of lopinavir/ritonavir vs. lopinavir/ritonavir plus umifenovir in patients with COVID-19. Open-label RCT (NCT04252885, recruiting). Prim"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T68","span":{"begin":159,"end":164},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"m Hg or respiratory rate ≥ 30 breaths per minute).\n• Comparison of lopinavir/ritonavir vs. lopinavir/ritonavir plus umifenovir in patients with COVID-19. Open-label RCT (NCT04252885, recruiting). Prim"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T98","span":{"begin":2,"end":4},"obj":"Chemical"},{"id":"T100","span":{"begin":67,"end":86},"obj":"Chemical"},{"id":"T101","span":{"begin":67,"end":76},"obj":"Chemical"},{"id":"T102","span":{"begin":77,"end":86},"obj":"Chemical"},{"id":"T103","span":{"begin":91,"end":110},"obj":"Chemical"},{"id":"T104","span":{"begin":91,"end":100},"obj":"Chemical"},{"id":"T105","span":{"begin":101,"end":110},"obj":"Chemical"},{"id":"T106","span":{"begin":116,"end":126},"obj":"Chemical"},{"id":"T107","span":{"begin":159,"end":164},"obj":"Chemical"}],"attributes":[{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_16170"},{"id":"A99","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_25195"},{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A101","pred":"chebi_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A103","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A104","pred":"chebi_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A105","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A106","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"},{"id":"A107","pred":"chebi_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"m Hg or respiratory rate ≥ 30 breaths per minute).\n• Comparison of lopinavir/ritonavir vs. lopinavir/ritonavir plus umifenovir in patients with COVID-19. Open-label RCT (NCT04252885, recruiting). Prim"}

{"project":"LitCovid-sentences","denotations":[{"id":"T102","span":{"begin":51,"end":153},"obj":"Sentence"},{"id":"T103","span":{"begin":154,"end":195},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"m Hg or respiratory rate ≥ 30 breaths per minute).\n• Comparison of lopinavir/ritonavir vs. lopinavir/ritonavir plus umifenovir in patients with COVID-19. Open-label RCT (NCT04252885, recruiting). Prim"}